MELANIE MOONEY: Open Payments
NPI 1932125069 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,973 in 105 payments from 27 companies in 2025. Trend: 2023 $1,578 · 2024 $1,966 · 2025 $1,973
Food & beverage: $1,973
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $314 |
| Insulet Corporation | 14 | $287 |
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| Abbott Laboratories | 10 | $150 |
| Amgen Inc. | 7 | $119 |
| ABBVIE INC. | 4 | $91 |
| Sequel Med Tech, LLC | 3 | $90 |
| Antares Pharma, Inc. | 5 | $81 |
| Lilly USA, LLC | 4 | $70 |
| Ascendis Pharma Endocrinology Inc | 3 | $63 |
Products named: Omnipod, LEQVIO, Ozempic, FREESTYLE LIBRE 3, Wegovy, TWIIST, XYOSTED, REPATHA.
Industry payments across KY — which companies pay providers there.
